NCT04008992View on ClinicalTrials.gov

An Ascending Dose Study of BMS-986259 to Study Safety in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

June 18, 2019

Primary Completion Date

January 4, 2021

Study Completion Date

January 4, 2021

Conditions
Healthy Participants
Interventions
DRUG

BMS-986259

Single and Multiple ascending dose from Dose 1 to Dose 5

OTHER

Placebo

Placebo matching BMS-986259

DIAGNOSTIC_TEST

P-Aminohippurate

Diagnostic Agent

DIAGNOSTIC_TEST

Iohexol

Diagnostic Agent

Trial Locations (2)

9728 NZ

PRA Health Sciences - Groningen, Groningen

SE1 1YR

Richmond Pharmacology, London

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY